Home - Products - Autophagy - Thrombin - Ozagrel

Ozagrel

CAS No. 82571-53-7

Ozagrel( OKY-046 )

Catalog No. M16065 CAS No. 82571-53-7

Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	29	In Stock
10MG	37	In Stock
25MG	67	In Stock
50MG	100	In Stock
100MG	152	In Stock
200MG	Get Quote	In Stock
500MG	368	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Ozagrel
Note

Research use only, not for human use.
Brief Description

Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet.
Description

Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet, used for the improvement of postoperative cerebrovascular contraction and accompanying cerebral ischaemia.
In Vitro

——
In Vivo

——
Synonyms

OKY-046
Pathway

Autophagy
Target

Thrombin
Recptor

Thromboxane A2 synthetase
Research Area

Cardiovascular Disease
Indication

——

Chemical Information

CAS Number

82571-53-7
Formula Weight

228.25
Molecular Formula

C13H12N2O2
Purity

>98% (HPLC)
Solubility

DMSO: 46 mg/mL (201.53 mM)
SMILES

C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Ishitsuka Y, et al. J Pharmacol Sci, 2009, 111(2), 211-215.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Naroparcil

Naroparcil, an orally available thioglycoside analog of 4-methylumbelliferyl β-D-xyloside, showed antithrombotic effects in the Wessler sludge model of venous thrombosis (jugular vein).
Eltrombopag

Eltrombopag is an orally active thrombopoietin receptor agonist with megakaryopoiesis stimulating activity.
Imitrodast

Imitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.

Sign In Join Free